Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05141032 · ClinicalTrials.gov registry record

Pathfinder Registry

A clinical trial, sponsored by Baylor College of Medicine.

Completed
Registry status
109
Enrollment target

NCT05141032 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 109 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05141032 has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
109 participants
Enrollment target

Study Summary

This study collects information regarding your procedure. No changes will be done to your procedure and you are asked to consent for the use of your data in our database. You are being asked to be in this research study because you have a gastrointestinal lesion that needs to be removed. We remove these lesions endoscopically as part of the standard of care at Baylor St. Luke Medical Center, and we will be using a FDA approved device known as the Pathfinder Rigidization Overtube to assist with the removal of the polyp. This study is important because this is a relatively new procedure; although it is a part of your standard of care it is not done in many hospitals. We would like to document the outcomes and results of such procedures to continuously improve our standard of care.

Interventions

  • PROCEDURE Endoscopic Submucosal Dissection with Pathfinder/Overtube device

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2021-10-18
Est. Completion 2023-11-01

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT05141032

The ClinicalTrials.gov registry entry for NCT05141032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Endoscopic Submucosal Dissection with Pathfinder/Overtube device is the first listed.

NCT05141032 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05141032 about?

NCT05141032 is a clinical study titled "Pathfinder Registry". This study collects information regarding your procedure. No changes will be done to your procedure and you are asked to consent for the use of your data in our database. You are being asked to be in this research study because you have a gastrointestinal lesion that needs to be removed. We remove t...

What is the current status of trial NCT05141032?

This trial is currently completed. The enrollment target is 109 participants. The study started on 2021-10-18. Estimated completion is 2023-11-01.

What interventions are being tested in trial NCT05141032?

The interventions under investigation include: Endoscopic Submucosal Dissection with Pathfinder/Overtube device (PROCEDURE).

Who is sponsoring clinical trial NCT05141032?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.